pH News and Research

RSS

pH comes from the term “power of Hydrogen”, or the hydrogen ion concentration present in a given solution. It helps to measure the acidity or alkalinity of a substance.

Savient's KRYSTEXXA receives FDA approval for chronic gout in adult patients refractory to conventional therapy

Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.

15 Sep 2010

Rib-X Pharmaceuticals presents positive preclinical data for delafloxacin at ICAAC Conference

Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced the presentation of positive preclinical data for delafloxacin in four poster sessions at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

14 Sep 2010

ARIAD commences ponatinib Phase 2 clinical trial in Ph+ ALL and chronic myeloid leukemia

ARIAD Pharmaceuticals, Inc. today announced the initiation of the pivotal Phase 2 clinical trial of its investigational pan-BCR-ABL inhibitor, ponatinib (previously known as AP24534), in patients with resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL).

13 Sep 2010

Scientists find low levels of bacteria in fields sprayed with swine manure

That swine manure sprayed on to fields adds valuable nutrients to the soil is well known. But what is not known is whether all that manure is bringing harmful bacteria with it.

13 Sep 2010

Six California-based institutions collaborate to guide CDU

Six California-based institutions specializing in health, hospital, university and nonprofit health announced today the formation of a new and unprecedented collaboration effort to rescue, restructure, reinvigorate and guide Charles R. Drew University of Medicine and Science (CDU) towards a new, resurgent and financially viable future.

13 Sep 2010

Severe eye problems at cattle show

After nearly fifty people complained of serious eye irritations, the dairy cow pavilion at the Royal Adelaide Show has been closed down. Organizers are blaming stagnant urine for the irritations. St John Ambulance volunteers were called to the Dairy Cattle pavilion after some people reported irritation to their eyes. 30 people required treatment at the site. 20 more people reported to the emergency department of the Royal Adelaide Hospital where their eyes were washed.

8 Sep 2010

Shared needle at school science experiment puts students at risk

In a science experiment at a Tasmanian Dover District high school, a teacher took blood samples from grade 9 and 10 students using the same needle. They were testing blood pH levels. Now students are being tested for HIV infection. The needle was dipped in methylated spirits each time before pricking but authorities say this is not enough to prevent transmission of HIV and other viruses like Hepatitis B and C.

8 Sep 2010

Unpredictable food poisoning

While we are often exposed to bacteria in our food which could cause food poisoning, we don't always become ill - why should this be so?

6 Sep 2010

CDC launches new online video to provide information on Assisted Reproductive Technology

Reproductive health experts at the Centers for Disease Control and Prevention (CDC) have launched three new online videos to provide science-based information for anyone considering Assisted Reproductive Technology (ART).

2 Sep 2010

Covidien completes sale of Sleep Therapy CPAP, Bi-level products to PH Invest

Covidien, a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Sleep Therapy continuous positive airway pressure and Bi-level products to PH Invest, a privately held company located in Luxembourg. Financial terms of the transaction were not disclosed.

30 Aug 2010

U-M researchers explore prevention measures, treatments for C. difficile infection

Clostridium difficile, a wily, familiar bacterium, causes a growing number of serious infections in U.S. hospitals and nursing homes. With a $7.5 million, five-year award from the National Institutes of Health, University of Michigan researchers plan to discover what factors in the microbe and in patients make C. difficile a formidable, costly problem.

27 Aug 2010

Vitamin D may be effective in preventing allergies in patients cystic fibrosis, asthma

Vitamin D may be an effective therapy to treat and even prevent allergy to a common mold that can cause severe complications for patients with cystic fibrosis and asthma.

26 Aug 2010

Parker Hannifin appoints 17 distributors as Instrumentation Solution Centers

Parker Hannifin Corporation, the global leader in motion and control technologies, today announced the establishment of the Instrumentation Group's Instrumentation Solution Centers, a special distinction given to its top-performing North American distributors.

21 Aug 2010

US oncology announces its contributions in development of 42 novel cancer therapies

US Oncology, Inc., the nation's leading integrated oncology company, announced today that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration.

21 Aug 2010

Tasigna receives approval for chronic myeloid leukemia in Canada

Tasigna (nilotinib) capsules have been approved with conditions in Canada as a new therapy for patients with CML, in the chronic phase (first phase) of the disease. Patients must be resistant to or intolerant of at least one prior therapy, including (Pr)Gleevec (imatinib mesylate), an established standard of care.

20 Aug 2010

New coverage for colorectal cancer screening to drive US markets for gastrointestinal endoscopy devices in 2010

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, new coverage instituted under the Patient Protection and Affordable Care Act of 2010 will remove the financial disincentives associated with colorectal cancer screening for a large segment of the US population. As a result of these changes in reimbursement, a growing number of colorectal cancer screening procedures will be performed through 2014, driving sales of many gastrointestinal endoscopy devices, including videoscopes and biopsy forceps.

20 Aug 2010

Renin test can predict appropriate drugs for BP patients: Study

Commonly prescribed drugs used to lower blood pressure can actually have the opposite effect-raising blood pressure in a statistically significant percentage of patients. A new study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that doctors could avoid this problem-and select drugs most suitable for their patients-by measuring blood levels of the enzyme renin through a blood test that is becoming more widely available. The study appears in the online edition of the American Journal of Hypertension.

20 Aug 2010

Montana Pain Management in breach of non-disclosure/non-circumvention agreement with Cannabis Science

Cannabis Science Inc., a pioneering US biotech company developing pharmaceutical cannabis products, reports that Cannabis Science sent an email to Mr. Rick Rosio on July 23, 2010 notifying him that he appeared to be in serious breach of the non-disclosure/non-circumvention agreement that he and Montana Pain Management, Inc., had signed with Cannabis Science.

19 Aug 2010

Cannabis Science signs manufacturing and development license with RockBrook

Cannabis Science Inc. a pioneering US biotech company developing pharmaceutical cannabis products, announces that on August 18, 2010, Cannabis Science signed with RockBrook Inc., its first manufacturing and development license for the Cannabis Science Brand of Pharmaceutical Products for the State of Colorado.

19 Aug 2010

Genome-wide study identifies key genetic variant associated with nonalcoholic fatty liver disease

Researchers at Massachusetts General Hospital found that patients with nonalcoholic fatty liver disease (NAFLD) who carry an allele of the PNPLA3 gene have an increased risk of developing advanced disease, including nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis. A second study supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) validates these findings and further concludes that in pediatric patients, the same allele is associated with earlier disease presentation.

18 Aug 2010

pH News and Research

Further Reading

Savient's KRYSTEXXA receives FDA approval for chronic gout in adult patients refractory to conventional therapy

Rib-X Pharmaceuticals presents positive preclinical data for delafloxacin at ICAAC Conference

ARIAD commences ponatinib Phase 2 clinical trial in Ph+ ALL and chronic myeloid leukemia

Scientists find low levels of bacteria in fields sprayed with swine manure

Six California-based institutions collaborate to guide CDU

Severe eye problems at cattle show

Shared needle at school science experiment puts students at risk

Unpredictable food poisoning

CDC launches new online video to provide information on Assisted Reproductive Technology

Covidien completes sale of Sleep Therapy CPAP, Bi-level products to PH Invest

U-M researchers explore prevention measures, treatments for C. difficile infection

Vitamin D may be effective in preventing allergies in patients cystic fibrosis, asthma

Parker Hannifin appoints 17 distributors as Instrumentation Solution Centers

US oncology announces its contributions in development of 42 novel cancer therapies

Tasigna receives approval for chronic myeloid leukemia in Canada

New coverage for colorectal cancer screening to drive US markets for gastrointestinal endoscopy devices in 2010

Renin test can predict appropriate drugs for BP patients: Study

Montana Pain Management in breach of non-disclosure/non-circumvention agreement with Cannabis Science

Cannabis Science signs manufacturing and development license with RockBrook

Genome-wide study identifies key genetic variant associated with nonalcoholic fatty liver disease

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo